MARKET

CSTL

CSTL

Castle Biosciences
NASDAQ
18.88
+0.73
+4.02%
After Hours: 18.88 0 0.00% 18:04 05/14 EDT
OPEN
18.25
PREV CLOSE
18.15
HIGH
19.00
LOW
17.72
VOLUME
652.48K
TURNOVER
--
52 WEEK HIGH
44.28
52 WEEK LOW
14.59
MARKET CAP
572.63M
P/E (TTM)
-43.9581
1D
5D
1M
3M
1Y
5Y
1D
Castle Biosciences price target lowered to $40 from $50 at BTIG
TipRanks · 1d ago
Castle Biosciences to Present at the 2026 Jefferies Global Healthcare Conference
PR Newswire · 1d ago
Castle Biosciences: Buy Reiterated on Strong Q1 Execution and Undervalued Growth Potential Despite Price Target Trim to $40
TipRanks · 1d ago
Castle Biosciences Price Target Cut to $40.00/Share From $50.00 by BTIG
Dow Jones · 1d ago
Castle Biosciences Is Maintained at Buy by BTIG
Dow Jones · 1d ago
BTIG Maintains Buy on Castle Biosciences, Lowers Price Target to $40
Benzinga · 1d ago
U.S. RESEARCH ROUNDUP-Aecom, Humana, Mosaic
Reuters · 1d ago
CASTLE BIOSCIENCES INC <CSTL.O>: BTIG CUTS TARGET PRICE TO $40 FROM $50
Reuters · 2d ago
More
About CSTL
Castle Biosciences, Inc. is a molecular diagnostics company offering test solutions to aid clinicians in the diagnosis and treatment of dermatologic cancers, Barrett’s esophagus (BE), uveal melanoma (UM), and in the treatment of mental health conditions. The Company offers around six commercially available proprietary multi-analyte assays with algorithmic analysis (MAAA) tests for use in the fields of dermatology, gastroenterology ophthalmology and includes a test to guide systemic treatment decisions in patients with moderate-to-severe AD. It also offers a proprietary pharmacogenomic (PGx) test to guide optimal drug treatment for patients diagnosed with depression, anxiety and other mental health conditions. Its products include DecisionDx-Melanoma, DecisionDx-SCC, MyPath Melanoma, TissueCypher, IDgenetix, and DecisionDx-UM. DecisionDx-SCC is its proprietary gene expression profile (GEP) test for patients with cutaneous squamous cell carcinoma (SCC).

Webull offers Castle Biosciences Inc stock information, including NASDAQ: CSTL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CSTL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CSTL stock methods without spending real money on the virtual paper trading platform.